U.S. market Closed. Opens in 17 hours 25 minutes

TGTX | TG Therapeutics, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for TGTX we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is wealthy, Growth is good and Health is passable.

Valuation (38%)

Company Industry
P/E Ratio (TTM) 35.33 -23.05
PEG Ratio (TTM) 0.27 15.47
P/S Ratio (TTM) 10.43 49.46
P/B Ratio (TTM) 19.04 18.87
P/FCF Ratio (TTM) 53.33 -3.27
Price to 5YR AVG Earnings Ratio -13.56 -3.55
Price to 5YR AVG FCF Ratio -21.24 -9.37

Profitability (65%)

Company Industry
ROA (TTM) 23.85% -5.14%
ROE (TTM) -38.21% 16.69%
Net Profit Margin (TTM) 27.60% -1,583.93%
ROIC 5YR AVG 26.07% 15.15%

Growth (65%)

4QTR AVG 3YR AVG 5YR AVG
EPS 103.62% -6.30% 26.18%
Revenue 229.55% 1,433.55% 2,506.46%
Net Income 104.16% -29.05% 12.35%
Cash Flow 97.20% -34.12% 4.05%

Health (60%)

Company Industry
Current Ratio (TTM) 3.58 6.13
Quick Ratio (TTM) 2.83 5.85
D/E Ratio (TTM) 0.58 -15.81
Interest Coverage (TTM) 8.21 -1.57
Piotroski F-Score 5 5
Altman Z-Score 6.86 14.12
LTL to 5YR AVG FCF -0.59 0.17
Shares Outstanding Growth 5YR AVG 13.90% 123.44%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙